Aptus Pharma IPO GMP & Review: Apply or Avoid?

Click Here and Sign Up to Get Verdicts on Aptus Pharma IPO

Aptus Pharma IPO is open for bidding from 23rd September 2025 to 25th September 2025. It is a bookbuilding IPO of ₹13.02 crore, comprising a fresh issue of 0.19 crore shares. The problem will be listed on BSE and SME on its tentative listing date, 30th September 2025.

Aptus Pharma IPO Details 

The Aptus Pharma IPO date is fixed between 23rd September 2025 and 25th September 2025. The face value of Aptus Pharma IPO shares stands at ₹10 per share, and the IPO price is set at ₹65.00 to ₹70.00 per share.

Bigshare Services Private Limited is the registrar of the Aptus Pharma IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

Aptus Pharma IPO Share Reservation

Aptus Pharma IPO is a bookbuilding IPO of ₹13.02 crores, comprising a fresh issue of 0.19 crore shares of Aptus Pharma, which will be listed on the BSE and SME. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Aptus Pharma IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Would you like to receive live updates on the Aptus Pharma IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of 19th September 2025, Aptus Pharma IPO GMP stands at ₹7 per share, which means the share will likely show a listing at ₹77 on its tentative listing date, 30th September 2025.

GMP data is subject to change based on market trends and sentiments. Please verify the live GMP status before applying for the Aptus Pharma IPO GMP. Stay informed with Univest to know about real-time insights on IPOs and their GMP trends. 

Aptus Pharma IPO GMP Review

Check out the detailed Aptus Pharma  GMP IPO review for a thorough understanding of its potential to report listing gains on 30th September 2025. The Aptus Pharma IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Therefore, it is crucial to comprehend the business’s financial growth margins and declines before applying for the Aptus Pharma IPO.

Aptus Pharma  Limited’s revenue increased by 38% from ₹17.88 crores in March 2024 to ₹24.64 crores in March 2025. Moreover, the company’s PAT rose by 288% from ₹0.80 crores to ₹3.10 crores.

Aptus Pharma  Limited’s IPO has shown consistent revenue growth, indicating that the company is financially stable. Moreover, brokers, investors, and RAs have a positive outlook for the Aptus Pharma IPO, with its tentative listing day set for 30th September 2025.  

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Aptus Pharma IPO.

The P/E ratio of Aptus Pharma Limited’s shares is 11.29, and its Earnings Per Share (EPS) stands at ₹ 6.20. Thus, the Aptus Pharma  Limited IPO is expected to deliver gains on its tentative listing date, 30th September 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Aptus Pharma  Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Aptus Pharma IPO Subscription Status

The Aptus Pharma IPO is to be opened for bidding on 23rd September 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Aptus Pharma IPO subscription status. 

About Aptus Pharma Limited

Prime Cable Industries Limited was Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations The company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.

Aptus Pharma Limited Financials

The company’s financial analysis is crucial before applying for the Aptus Pharma IPO. Refer to the table to learn about Aptus Pharma Limited’s financials. 

Explanation

Aptus Pharma  Limited’s revenue increased by 38% from ₹17.88 crores in March 2024 to ₹24.64 crores in March 2025. Moreover, the company’s PAT rose by 288% from ₹0.80 crores to ₹3.10 crores.

Aptus Pharma IPO Bidding Requirements

Investors can bid for a minimum of 4,000 shares and in multiples of 2,000 thereof. The following table represents the minimum and maximum investments by individual investors (retail) and HNI in terms of shares and amount.

EcolineExim’s IPO has reserved lot sizes for different investor categories. Look at the table below to see the requirements for applying for this IPO.

Use the lot size calculator to find how many shares you should apply for!

Aptus Pharma IPO Promoter Holding

Take a look at the table below to review the holdings of Aptus Pharma  Limited’s promoters: Rakesh Ashok Markhedkar, Avinash Markhedkar, and Nakul Markhedkar.

Note: The value will be calculated using Equity Dilution = Share Holding Pre-Issue – Share Holding Post-Issue.

Aim of the Aptus Pharma IPO

The primary aim of the Aptus Pharma IPO is to raise ₹13.02 crores. On the other hand, Aptus Pharma has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Aptus Pharma IPO.

• To Capital Expenditure for Office Premises with furniture and Industrial Racks
• To Working Capital
• For general corporate purposes

Should I Invest in the Aptus Pharma IPO?

Explore the pros and cons of Aptus Pharma to know whether you should apply or avoid the issue. These pros and cons might help you know about the IPO’s efficiency in delivering profits in the coming decades. 

Pros of Aptus Pharma IPO

• Aptus Pharma has a diversified product portfolio.
• The company has a robust distribution network
• The competitive and cost-effective pricing
• The company has an experienced management team

Cons of Aptus Pharma IPO

• The company has no own manufacturing facility
• The company has a significant portion of its revenue from a few customers
• The company has a working capital intensity

How to Apply for the Aptus Pharma IPO?

Please follow the steps outlined below to apply for Aptus Pharma Limited.

• Step 1: Conduct thorough research on the Aptus Pharma IPO, including GMP, subscription status, issue size, lot size, and other relevant details. 
• Step 2: Open a demat account on Univest to learn about real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Make a bid for two lots of 4,000 shares worth ₹2,80,000.
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Aptus Pharma IPO from more than one demat account to increase your chances of allotment. 

How to Check Aptus Pharma IPO Allotment Status?

You can check whether the Aptus Pharma IPO allotment has been completed in different ways. These include NSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.

Check On BSE

• Visit the BSE Official Website.
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the Aptus Pharma IPO.  
• Choose whether to proceed with the PAN number or the application number. 
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal.
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Jaro Institute IPO allotment status.

Let’s Wrap

The Aptus Pharma IPO is a book-building issue of shares worth ₹13.02 crore. The shares of Aptus Pharma  Limited will be listed on BSE and SME on its tentative listing date of 30th September 2025. Researching the Aptus Pharma IPO GMP and reviews is highly suggested to book your ideal profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

FAQs on Aptus Pharma IPO

How is the Aptus Pharma IPO?

Ans. Currently, on 19th September 2025, the Aptus Pharma IPO GMP (Grey Market Premium) stands at ₹7. It indicates that the estimated listing price could be ₹77 per share. It is a bookbuilding IPO of ₹13.02 crores, comprising a fresh issue of 0.19 crore shares. The face value of each share of Aptus Pharma Limited is ₹10 per share.

What is the Aptus Pharma IPO price?

Ans. The Aptus Pharma IPO price is set at ₹65.00 to ₹70.00 per share.  Retail investors can apply for a minimum of 2 lots consisting of 4,000 shares worth ₹2,80,000. Moreover, HNIs are required to bid for a minimum of 3 lots (6,000 shares) worth ₹4,20,000.

Is the SolarWorld Energy Solutions IPO a good investment?

Ans. Aptus Pharma  Limited’s revenue increased by 38% from ₹17.88 crores in March 2024 to ₹24.64 crores in March 2025. Moreover, the company’s PAT rose by 288% from ₹0.80 crores to ₹3.10 crores.

Who is the registrar of the Aptus Pharma IPO?

Ans. Bigshare Services Private Limited is the registrar of the Aptus Pharma IPO, responsible for managing the allotment procedure and initiating refunds. For any queries regarding the Aptus Pharma allotment and refund, please contact Bigshare Services Private Limited at investor@bigshareonline.com  or +91-22-6263 8200.

What is the issue size of the Aptus Pharma IPO?  

Ans. The Aptus Pharma IPO is a book-building IPO for 0.19 crore shares, valued at ₹13.02 crore. Moreover, the IPO is set to open on 23rd September 2025 and will be closed on 25th September 2025. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Aptus Pharma IPO, download the Aptus Pharma IPO RHP and Aptus Pharma IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Upcoming IPOs

Current & Previous IPOs

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest in India

Also Explore

Univest Screeners

Explore Webstories on Univest 

1. Best Time To Buy Dividend Stocks

2. How RBI Policies Affect Dividend Stocks

3. Can Dividend Stocks Beat Inflation

4. What Is The Dividend Aristocrat List

5. Which Indian Psus Offer The Best Dividends

6. Large Cap Vs Small Cap Dividend Stocks